Cambridge, UK, 27 January 2025: Harness Therapeutics (‘Harness’), a biotechnology company unlocking previously undruggable targets to transform the treatment of neurodegenerative diseases, today ...
Cambridge, UK, September 4, 2024: Harness Therapeutics, a biotechnology company focused on protein upregulation to develop disease-modifying therapeutics for neurodegenerative diseases, today ...
Dr Heather Preston, seasoned healthcare investor with over 30 years' experience as a scientist, physician, management consultant, and Board adviser, joins as Chair Funding recognises Harness' ...